Paz Abercohen, Yuval Horn and Yonatan Levinstein of Horn & Co. represented Raziel Therapeutics in its $22 million series C round, led by Pontifax, with participation from existing investors as well as new investors, Catalyst Fund, Quark venture, Peregrine Investments and Wille AG.
December 18, 2019
International Divorce Conference
November 25, 2019
Yuval Horn will moderate a panel about AI and eHealth disruption in the medical and lifestyle markets with Markus von Fuchs at the upcoming IBA 6th Biennial Technology Law Conference in Berlin.
October 10, 2019
Yuval Horn moderated a panel with Rabel Z. Akhund on the regulation of crypto trading platforms.
September 25, 2019
Yuval Horn moderated, with Doil Son of Yulchon (Seoul) a panel on Data in M&A at the Annual Meeting of the International Bar Association in Seoul.
September 24, 2019
Paz Abercohen of Horn & Co. represented Biolight Life Sciences Ltd. in its investment in Sanoculis Ltd., a medical device company which develops an innovative surgical procedure for treatment of Glaucoma
September 15, 2019
Proud to be ranked, again, by IAM Magazine (Intellectual Asset Management) as one of top 5 “highly recommended” Israeli firms in intellectual property transactions
July 1, 2019
Cyber Incident Response and Data Breach Notification
May 1, 2019
Information security consideration (Israel)
May 1, 2019
Horn & Co. has been recognized by Legal 500 as a “Tier 1” firm in Israel in the field of Healthcare and Life Sciences. Yuval Horn was noted as a Tier I practitioner. Legal 500 notes: “Horn & Co is known for providing top-quality service, particularly to pharmaceutical companies and investors, in relation to IP, commercial agreements, M&A and regulatory matters.” The firm was further recognized as a leading firm in the fields of Hi-tech and start-ups and IP transactions.
April 1, 2019
